MannKind: Afrezza's slow start comparable to launch of Toyota Prius
MannKind says it is confident sales of its inhaled insulin product Afrezza - commercialised by Sanofi - will pick up after disappointing growth since launch.
Archives for November 10, 2015
Parexel expands late-phase service focus through Access division
Parexel has reorganised its Phase IIIb/IV offerings to cope with growing demand in market access and product lifecycle services from pharma firms.
Clarification
Repligen halting one Protein A media programme but still in resin market
Repligen has halted a Protein A media programme due to mixed feedback and dilution risks but says it is still a player in the $350m market.
Unilife undecided on takeover plans; gives December 31 deadline
Unilife CEO Alan Shortall yesterday confirmed the drug delivery company is still “receiving interest from several parties under the strategic review process” and set a deadline of December 31 to announce any potential takeover. The company received its...
Recipharm signs $25m API contract extension with SK’s Daewoong
CDMO Recipharm has signed a €25m ($26.7m) contract to supply API for Korean multinational Daewoong to make and market the respiratory drug Erdosteine.